)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Emcure Pharmaceuticals (EMCURE) investor relations material
Emcure Pharmaceuticals Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary7 Aug, 2025
Executive summary
Revenue grew 15.7–16% year-over-year, with EBITDA up 20% and profit after tax rising 41% to INR 215 crores, marking the highest quarterly profit.
All business verticals and geographies showed strong growth, with domestic and international segments outperforming industry trends.
EBITDA margin improved to 19.2%, with PAT margin at 10.2%.
Strategic focus on innovation, partnerships, and new geographies underpins a five-year vision for above-industry growth and margin improvement.
Expanded partnership with Sanofi to include oral diabetes portfolio, with key brands launching from August.
Financial highlights
Revenue from operations reached INR 2,101 crores, up 15.7–16% year-over-year.
Domestic business grew 9.4% to INR 995 crores; international business rose 22–22.1% to INR 1,106 crores.
Emerging markets surged 42% to INR 360 crores; Canada up 16.4% to INR 342 crores; Europe up 12.8% to INR 403 crores.
Gross margin was 61.8%, up from 57.8% in the previous quarter.
Profit after tax was INR 215 crores, up 41% year-over-year; earnings per share rose to Rs. 10.92.
Outlook and guidance
Targeting volume growth of 4–5% for the full year in India, with new launches contributing 1–2%.
Sanofi diabetes portfolio expected to add INR 200 crores annualized, with 7–8 months' contribution this year.
Five-year vision aims for growth 2% above industry and 300–400 basis points margin expansion.
Emerging markets expected to grow in high teens to 20% for the year.
Acquisition of minority shares in Zuventus Healthcare Ltd. expected to complete by September 2025.
Future blockbuster product focus areas?
Impact of acquisitions on debt repayment timeline?
Key pipeline products market ramp-up strategy?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Emcure Pharmaceuticals earnings date
Q2 25/267 Nov, 2025
Next Emcure Pharmaceuticals earnings date
Q2 25/267 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Emcure Pharmaceuticals Limited is an India-based pharmaceutical company involved in the development, manufacturing, and marketing of a broad range of pharmaceutical products. Emcure’s product portfolio includes prescription medicines, biologics, and over-the-counter products, covering therapeutic areas such as cardiology, oncology, nephrology, and anti-infectives. The company operates manufacturing facilities in India and has a significant presence in both domestic and international markets. The company is headquartered in Pune, India.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage